Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06467604 · ClinicalTrials.gov registry record

CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users

A clinical trial of Obesity, sponsored by University of California, Davis.

Active
Registry status
7
Enrollment target
1
Study location

NCT06467604: Active study of Obesity, sponsored by University of California, Davis.

NCT06467604 is a study of Obesity that is active but no longer recruiting, run by University of California, Davis. The registered enrollment target is 7 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06467604, a study of Obesity, is active but no longer recruiting, sponsored by University of California, Davis.

ACTIVE NOT RECRUITING
Registry status
7 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess the impact of GLP-1 receptor agonists, semaglutide and tirzepatide, on food cravings and diet quality in individuals with overweight or obesity. Over 24 weeks, up to 150 adult participants will be monitored using questionnaires and dietary records at 0, 12, and 24 weeks to measure changes in diet quality, disordered eating, food cravings, and hunger. This research, conducted with Seen Medical Group at Knownwell Health Clinic, seeks to fill the gap in literature on the dietary quality effects of GLP-1RAs.

Primary Outcome

Effect of GLP1 medications on food cravings measured by the food-craving inventory (FCI-II) questionnaire.The FCI-II is scored on a Likert scale from 1-5, with 1 being "Never," 5 being "Always/Almost every day."

Conditions Studied

Obesity

Interventions

  • BEHAVIORAL Surveys
  • OTHER Indirect Calorimetry
  • OTHER Body composition
  • OTHER Anthropometrics

Study Locations (1)

Massachusetts

  • Knownwell - Needham

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2024-11-01
Est. Completion 2026-04-01
University of California, Davis

657 total trials

What the registry record for NCT06467604 still lists

NCT06467604 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Surveys is the first listed.

NCT06467604 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06467604 about?

NCT06467604 is a clinical study titled "CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users". This study aims to assess the impact of GLP-1 receptor agonists, semaglutide and tirzepatide, on food cravings and diet quality in individuals with overweight or obesity. Over 24 weeks, up to 150 adult participants will be monitored using questionnaires and dietary records at 0, 12, and 24 weeks to ...

What is the current status of trial NCT06467604?

This trial is currently active not recruiting. The enrollment target is 7 participants. The study started on 2024-11-01. Estimated completion is 2026-04-01.

What conditions does trial NCT06467604 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT06467604?

The interventions under investigation include: Surveys (BEHAVIORAL), Indirect Calorimetry (OTHER), Body composition (OTHER), Anthropometrics (OTHER).

Who is sponsoring clinical trial NCT06467604?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06467604 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06467604's enrollment target sits among peer trials

7 1045th of 1053 higher than 7 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06467604, the US trial registry maintained by the National Library of Medicine. NCT06467604 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.